Ir para o conteúdo
Global sound
The Bio Report

The Bio Report

Turning Abandoned Drugs into Breakthroughs

· 31 min · Episódio 175

Notas do episódio

Promising drugs can become abandoned or underused because of tolerability issues, poor drug‑like properties, or other fixable limitations, even when there is already compelling human evidence that they work. PureTech Health starts with an unmet need and human pharmacology, then systematically dissects and solves the specific liabilities of discontinued drugs to unlock breakthroughs in an approach that has proved to be a highly efficient means of value creation. Eric Elenko, president and co‑founder of PureTech, discusses the company’s disciplined approach to drug innovation around rescuing promising but discontinued therapeutics, its hub‑and‑spoke structure, and how this model can neutralize emotional bias, enforce clear success criteria, and turn partially derisked assets into commercial successes.

Site: thebioreport.podbean.com

Ao vivo, última hora: 7.705 músicas em 3.112 rádios de 125 países

Descubra o mundo pelo rádio

Mais formas de descobrir (7)

Ouviu algo legal? Salve ou abra direto no Spotify.

★ Artista da semana A maior subida na rádio esta semana
A tua música aqui? Desde € 9 por semana →
Mix FM SA 98.0 FMContinuar ouvindo